Migratory bone marrow edema syndrome (BMES) of the hip is a rare entity. We report the case of a 41-year old male with migratory BMES of the hip with eight months interval period between onset of the pain and consultation. This patient was successfully treated non-surgically. It is important to always inform the patient with unilateral BMES of the hip regarding the possibility of future involvement of the contralateral hip.
INTRODUCTION
Bone marrow edema syndrome (BMES) of the hip is an uncommon disease which is characterized by a self-limiting process 1 . It primarily affects middle-aged men, and women during the last trimester of pregnancy 1, 2 . BMES of the hip could present as a unilateral, simultaneous bilateral or a sequential/migratory case 3 . The migratory case is rare. We present a patient with a migratory BMES of the hips in association with a short review of previous similar case reports.
CASE REPORT
A 41-year old male came to our outpatient clinic with a one month history of right inguinal pain. The pain was localized, non-radiating, aggravated by activity and relieved by rest. Visual analog scale (VAS) was 7-8. There was no history of pain in any other joint, history of trauma, alcohol abuse, steroid medication or other related illness. He was a physically fit person and worked as an office staff. (Fig. 1 ). T2-weighted magnetic resonance imaging (MRI) showed high signal intensity which involved the right femoral head and neck with joint effusion (Fig. 2) . Bone mineral density (BMD) examination with dual energy radiograph absorptiometry (DEXA) showed the total bone density of the hip was 1.014 g/cm 2 (Tscore 0.6, Z-Score 0.6). Bone scintigraphy (Tc-99m) examination revealed increased uptake on the right hip centered on the femoral head. A diagnosis of BMES was arrived at based on clinical and radiological findings. He was managed symptomatically with an advice to rest, partialweight bearing with crutch walking and analgesia for pain control (45mg of Pelubiprofen and a combination of 162, 5mg Acetaminophen +18,75mg Tramadol) twice daily. Monthly radiographic examination during follow-up was planned. Clinical improvement was noticed at one month and subsequently the patient felt relieved of all symptoms.
About eight months after the initial onset, the patient visited our outpatient clinic complaining of a new onset of pain (VAS 6-7) on the opposite hip. He complained symptoms similar to that on his contralateral (right) hip previously. There was no history of significant event before onset of the recent pain. On physical examination of the right hip, there was no pain and range of motion of the hip was full. Physical examination of the left hip revealed positive Patrick's test with limitation of range of motion. As before, laboratory examination revealed normal results. Pelvic anteroposterior radiograph showed slight osteopenic area on the left femoral head and neck. T2-weighted MRI showed high signal intensity on left femoral head and neck with normal intensity on the right side (Fig. 3) . The total bone density was 1.019 g/cm 2 (T-score 0.6, Z-Score 0.6). At this second presentation, bone scintigraphy was not obtained. Due to similar clinical and image findings with previous contralateral right hip, we diagnosed this patient with having a migratory type of BMES of the left hip. Similar treatment protocol was instituted for the patient. Two months later pain had subsided and he had regained his normal activity level. He had no complaint on further follow-up at six months. Informed consent was obtained from the patient and his family for publication of this case report. 
DISCUSSION
We report migratory bone marrow edema syndrome of the hips occurring in a middle-aged male patient with less than a year of interval of onset between the two hips. Previously, several migratory BMES of the hip cases have been reported [1] [2] [3] [4] [5] . Interestingly, all of them were of the male gender, with age range between 20 to 52 years. A wide range of the interval period between onset in both hips has been reported. The shortest interval was four months in a case reported by Garzon et al 1 , while the longest interval period was 12 years as recently reported in a case by Iannò et al 3 (Table I) .
Several risk factors have been proposed to be associated with BMES of the hip including: repetitive trauma, heavy lifting occupation, steroid intake, alcoholism and hormonal/ neurovascular problem associated with pregnancy 2, 3 . One of the five previously reported cases had a history of hypothyroid state and had received thyroxin supplement 2 , while the other had a history of long term carbamazepine treatment 5 . Our patient had bilateral coxa valga based on radiographic findings (neck-shaft angle >135 o on both hips). Although a valgus hip is known to be associated with an increase in hip joint reaction force, its role as the risk factor for bone marrow edema syndrome remains unknown.
Symptomatic treatment remains the best choice for uncomplicated bilateral BMES of the hip. Treatment modalities from oral analgesic medication, oral/parenteral bisphosphonate, parenteral calcitonin to magnetotherapy have been reported 3, 4 . The use of antiresorptive agent (bisphosphonate/calcitonin) is controversial, as osteoporosis was not always present in the BMES of the hip cases. Bone mineral density was within normal limit in our current case. Yi et al 4 noted osteopenia of both hips on BMD measurement. Bolland 5 reported an inconsistent finding with only one hip showing osteoporosis with the other one normal. Despite different result on BMD measurement, our present case and the case reported by Yi et al 4 and Bolland 5 were succesfully treated with only protected weight bearing or in combination with analgesic medication. The use of antiresorptive agent may be more beneficial for those who failed with symptomatic treatement and for those with a high risk of fracture 5 .
In summary, it is important to always warn the patient with a unilateral BMES of the hip on the possibility of future contralateral hip involvement. We hope this report, along with the short review of previously reported cases, may have some value in understanding the migratory pattern of BMES of the hip.
